MerckSource received the 2006 WebAward for Outstanding Website Development from the Web Marketing Association at the annual WebAward competition.
MerckSource was honored at the Healthcare Internet Conference in Atlanta, receiving the 2006 Gold eHealthcare Leadership Award for best health/healthcare content.
MerckSource received the 2006 WWW site Award of Excellence from the Health Improvement Institute. This award honors excellence in health communications.
More Awards
Resource Library
Powered by:  |
This information is provided by an independent source. Merck & Co., Inc. is not responsible for this content. Please discuss any and all treatment options with your healthcare professional. The manufacturer of a product generally has the most complete information about that product. |
|
|
What Is Cancer Of The Uterus?
In cancer of the uterus, also called endometrial cancer, cancer cells are present in the inner lining of the uterus. The inner lining of the uterus is called the endometrium. Normally, the endometrium undergoes a series of changes during a woman's monthly menstrual cycle, in preparation for a potential pregnancy. The ovaries release hormones that initiate these changes. If pregnancy does not occur, the endometrial lining is shed during menstruation. A very small percentage of endometrial cancers grow in the muscular and connective tissues of the uterus. These tumors are called uterine sarcomas.
In the United States, cancer of the endometrium is the most common cancer of the female reproductive organs. The American Cancer Society estimates that 37,400 new cases of endometrial cancer will be diagnosed during 1999. About 6,400 women in the United States die each year from endometrial. When all cases of endometrial cancer are considered, the five-year survival rate is 84 percent. Survival rates are even higher when the disease is discovered and treated in its earliest stage, thus it is vital that women visit their physicians annually for a pelvic exam.
|
External Resources:
American Cancer Society. Endometrial Cancer Resource Center.
|
Homesley HD, Zaino R. Endometrial Cancer: prognostic factors. Seminars in Oncology. 1994;21(1):71-78.
|
National Cancer Institute. CancerNet Database. Treatment summaries. Endometrial Cancer. PDQ 9/99.
|
National Cancer Institute NIH Publication No.98-1562. Revised September 1997.
|
|
This article was reviewed by Simeon Margolis, M.D., Ph.D. Professor of Medicine, Endocrinology and Biological Chemistry The Johns Hopkins University School of Medicine 01/2003
Return to the previous page
This article was published on
1999-11-16 This article was reviewed on
2003-02-03
|
|
|
20351091(1)-12/03-EBS-CON